ARCHIVES

Low Prevalence Of Tamoxifen Use For Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 33 No. 2 | February 26, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Director To Decide Fate Of P-4 After NCAB Meeting In June.

April 20, 2007

Most Comprehensive Centers Score High; Few May Be In Trouble; Directors Back Program

May 19, 1978

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

February 17, 1989

DCE Advisors approver New Grant Programs In Ovarian Cancer, Biostatistics, Biotech Transfer; Support Services Recompetitions

June 19, 1992

Holland On The Next 10 Years; Progress In Prevention, Diagnosis, Therapy

March 23, 1984

DeVita Considers Alternatives to Recommendation Of NCAB On Organ Systems Coordinating Center

June 1, 1984